GSK2879552 is an orally active, irreversible, and selective mechanism-based inhibitor of lysine-specific demethylase 1 (LSD1). It exhibits antineoplastic activity and has been investigated in preclinical studies, including in vitro assays and in vivo models, for cancers such as small cell lung carcinoma and acute myeloid leukemia.
